Epidural Analgesia for Pediatric Surgery

This trial explores two methods of pain relief after surgery in children: a constant flow of pain medication (continuous infusion) and timed doses (intermittent bolus) through an epidural. Researchers aim to determine which method better manages pain and reduces the need for additional pain medication. They will also assess factors such as how soon children can resume normal eating and any side effects like low blood pressure. Children under 18 who have undergone a Kelly procedure or similar surgery and require at least three days of epidural pain relief may be suitable candidates for this trial. As an unphased trial, this study provides a unique opportunity to enhance understanding of effective pain management in children after surgery.

Research has shown that both continuous epidural infusion (CEI) and programmed intermittent epidural bolus (PIEB) are generally safe for managing pain in children after surgery.

For CEI with ropivacaine, studies have found it provides safe and effective pain relief, similar to other anesthetics like bupivacaine, without serious side effects. One study confirmed that epidural pain relief is safe and effective after various surgeries, including those for spinal issues.

When using chloroprocaine in CEI, results are mixed. Some studies report excellent pain relief with minor side effects, while others note a higher chance of side effects compared to other drugs, though the evidence is not consistent.

For PIEB, research suggests it may spread pain relief medication effectively, improving pain control without major side effects. In some cases, it even reduces the need for extra pain medication.

Researchers are excited about the trial exploring different methods of epidural analgesia for pediatric surgery because it aims to compare the effectiveness of continuous infusion versus programmed intermittent bolus of anesthetics. Unlike traditional methods, which often involve patient-controlled epidural analgesia, these techniques are managed without patient involvement, allowing for potentially more consistent pain management. The continuous infusion method delivers a steady flow of anesthetic, which might offer more stable pain relief, while the intermittent bolus approach provides periodic doses that could maximize pain control with potentially lower overall drug usage. By comparing these innovative delivery methods, researchers hope to discover more effective ways to manage pain for children undergoing surgery.

This trial will compare two methods of administering epidural analgesia for pediatric surgery: continuous epidural infusion (CEI) and programmed intermittent epidural bolus (PIEB). Studies have shown that both chloroprocaine and ropivacaine effectively relieve pain after surgery. In this trial, some participants will receive chloroprocaine, which, when administered continuously, reduces pain and the need for additional pain medication in babies and newborns. Research also suggests that administering chloroprocaine in small doses at intervals can improve surgical outcomes by better managing pain. Other participants will receive ropivacaine, which, whether given continuously or in small doses, significantly reduces opioid use and increases patient satisfaction. Administering ropivacaine in small doses at intervals, compared to continuous infusion, provides better pain relief and uses less anesthetic. These findings indicate promising benefits for both medications in managing postoperative pain in children.¹⁶⁷⁸⁹